Patients could find lifesaving benefits in using a home blood pressure cuff. New research finds that home blood pressure monitoring saves lives and cuts costs. It also reduces health care disparities in racial and ethnic minorities and rural residents. Furthermore, regular self-testing better controls high blood pressure, especially in underserved patients, reducing the risk of… read on > read on >
In areas where Black Americans have been historically affected by discriminatory housing practices, there is higher heart failure risk, according to new research. Researchers studying more than 2.3 million U.S. adults between 2014 and 2019 found that heart failure today was linked to “redlining,” which began in the 1930s. Heart failure risk for Black people… read on > read on >
While nursing home residents are at high risk for bad outcomes if they get COVID-19, use of antiviral treatments, such as monoclonal antibodies, was low through most of 2021 and 2022. The authors of a new study, led by Brian McGarry, a health services researcher at the University of Rochester Medical Center in New York,… read on > read on >
A new study offers the first-ever county-level estimates of Alzheimer’s disease in the United States. It shows that the East and Southeast have the highest prevalence of Alzheimer’s dementia, which researchers said may owe in part to the higher percentages of older people, and Black and Hispanic residents in those regions. The study covered all… read on > read on >
MONDAY, July 17, 2023 (HealthDay Now) — Parents now have a new long-acting drug to protect their children against respiratory syncytial virus (RSV), a common germ that hospitalizes as many as 3% of children under the age of 1 in the United States each year. The U.S. Food and Drug Administration on Monday approved Beyfortus… read on > read on >
People with type 2 diabetes could soon have access to convenient once-a-week insulin shots that could replace the daily injections now required. A once-weekly insulin formulation called icodec performed just as well as daily doses of the insulin degludec, phase 3 clinical trial results show. Icodec now awaits approval by the U.S. Food and Drug… read on > read on >
Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing disease. In research published online Monday in the Journal of the American Medical Association and presented simultaneously at the Alzheimer’s Association International Conference in Amsterdam, the drug donanemab slowed memory and thinking… read on > read on >
MONDAY, July 17, 2023 (American Heart Association News) — At 32, Allison Graff saw her life as a treasure. She loved her job in Florida. She owned her own home. She discovered the delights of dancing, which she did at clubs as often as possible. Working up a sweat and getting all tired out just… read on > read on >
The national 988 Suicide & Crisis Lifeline has hit its one-year anniversary, and it appears that the public is increasingly turning to the number in times of darkness. The most recent statistics show a substantial increase in call volume, with nearly 160,000 more crisis calls, chats and texts in May 2023 compared to May 2022… read on > read on >
If your child has ever taken a knock to the head on the playing field, a new study has some reassuring news: There’s no evidence that a concussion shaves points from a kid’s IQ. Researchers found that compared with children and teens who’d suffered broken bones or sprained ankles, those with a recent concussion did… read on > read on >
